These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

292 related articles for article (PubMed ID: 24713615)

  • 1. Alteration of the proteostasis network of plant cells promotes the post-endoplasmic reticulum trafficking of recombinant mutant (L444P) human β-glucocerebrosidase.
    Babajani G; Kermode AR
    Plant Signal Behav; 2014; 9(3):e28714. PubMed ID: 24713615
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Pharmacological chaperones facilitate the post-ER transport of recombinant N370S mutant β-glucocerebrosidase in plant cells: evidence that N370S is a folding mutant.
    Babajani G; Tropak MB; Mahuran DJ; Kermode AR
    Mol Genet Metab; 2012 Jul; 106(3):323-9. PubMed ID: 22592100
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Characterization of the ERAD process of the L444P mutant glucocerebrosidase variant.
    Bendikov-Bar I; Ron I; Filocamo M; Horowitz M
    Blood Cells Mol Dis; 2011 Jan; 46(1):4-10. PubMed ID: 21106416
    [TBL] [Abstract][Full Text] [Related]  

  • 4. ERdj3 is an endoplasmic reticulum degradation factor for mutant glucocerebrosidase variants linked to Gaucher's disease.
    Tan YL; Genereux JC; Pankow S; Aerts JM; Yates JR; Kelly JW
    Chem Biol; 2014 Aug; 21(8):967-76. PubMed ID: 25126989
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Remodeling the proteostasis network to rescue glucocerebrosidase variants by inhibiting ER-associated degradation and enhancing ER folding.
    Wang F; Segatori L
    PLoS One; 2013; 8(4):e61418. PubMed ID: 23620750
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Ca2+ homeostasis modulation enhances the amenability of L444P glucosylcerebrosidase to proteostasis regulation in patient-derived fibroblasts.
    Wang F; Agnello G; Sotolongo N; Segatori L
    ACS Chem Biol; 2011 Feb; 6(2):158-68. PubMed ID: 21043486
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Histone deacetylase inhibitors increase glucocerebrosidase activity in Gaucher disease by modulation of molecular chaperones.
    Yang C; Rahimpour S; Lu J; Pacak K; Ikejiri B; Brady RO; Zhuang Z
    Proc Natl Acad Sci U S A; 2013 Jan; 110(3):966-71. PubMed ID: 23277556
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Celastrol increases glucocerebrosidase activity in Gaucher disease by modulating molecular chaperones.
    Yang C; Swallows CL; Zhang C; Lu J; Xiao H; Brady RO; Zhuang Z
    Proc Natl Acad Sci U S A; 2014 Jan; 111(1):249-54. PubMed ID: 24351928
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Novel beta-glucocerebrosidase chaperone compounds identified from cell-based screening reduce pathologically accumulated glucosylsphingosine in iPS-derived neuronal cells.
    Naito Y; Sakamoto S; Kojima T; Homma M; Tanaka M; Matsui H
    SLAS Discov; 2023 Oct; 28(7):344-349. PubMed ID: 37369311
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The heat shock protein amplifier arimoclomol improves refolding, maturation and lysosomal activity of glucocerebrosidase.
    Fog CK; Zago P; Malini E; Solanko LM; Peruzzo P; Bornaes C; Magnoni R; Mehmedbasic A; Petersen NHT; Bembi B; Aerts JFMG; Dardis A; Kirkegaard T
    EBioMedicine; 2018 Dec; 38():142-153. PubMed ID: 30497978
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Chemical chaperones and permissive temperatures alter localization of Gaucher disease associated glucocerebrosidase variants.
    Sawkar AR; Schmitz M; Zimmer KP; Reczek D; Edmunds T; Balch WE; Kelly JW
    ACS Chem Biol; 2006 May; 1(4):235-51. PubMed ID: 17163678
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Gaucher disease paradigm: from ERAD to comorbidity.
    Bendikov-Bar I; Horowitz M
    Hum Mutat; 2012 Oct; 33(10):1398-407. PubMed ID: 22623374
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The pharmacological chaperone isofagomine increases the activity of the Gaucher disease L444P mutant form of beta-glucosidase.
    Khanna R; Benjamin ER; Pellegrino L; Schilling A; Rigat BA; Soska R; Nafar H; Ranes BE; Feng J; Lun Y; Powe AC; Palling DJ; Wustman BA; Schiffmann R; Mahuran DJ; Lockhart DJ; Valenzano KJ
    FEBS J; 2010 Apr; 277(7):1618-38. PubMed ID: 20148966
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Unfolded protein response in Gaucher disease: from human to Drosophila.
    Maor G; Rencus-Lazar S; Filocamo M; Steller H; Segal D; Horowitz M
    Orphanet J Rare Dis; 2013 Sep; 8():140. PubMed ID: 24020503
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Interaction between parkin and mutant glucocerebrosidase variants: a possible link between Parkinson disease and Gaucher disease.
    Ron I; Rapaport D; Horowitz M
    Hum Mol Genet; 2010 Oct; 19(19):3771-81. PubMed ID: 20643691
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Inhibition of endoplasmic reticulum-associated degradation rescues native folding in loss of function protein misfolding diseases.
    Wang F; Song W; Brancati G; Segatori L
    J Biol Chem; 2011 Dec; 286(50):43454-64. PubMed ID: 22006919
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Parkinson disease-linked GBA mutation effects reversed by molecular chaperones in human cell and fly models.
    Sanchez-Martinez A; Beavan M; Gegg ME; Chau KY; Whitworth AJ; Schapira AH
    Sci Rep; 2016 Aug; 6():31380. PubMed ID: 27539639
    [TBL] [Abstract][Full Text] [Related]  

  • 18. ITCH regulates degradation of mutant glucocerebrosidase: implications to Gaucher disease.
    Maor G; Filocamo M; Horowitz M
    Hum Mol Genet; 2013 Apr; 22(7):1316-27. PubMed ID: 23255161
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Mutant glucocerebrosidase in Gaucher disease recruits Hsp27 to the Hsp90 chaperone complex for proteasomal degradation.
    Yang C; Wang H; Zhu D; Hong CS; Dmitriev P; Zhang C; Li Y; Ikejiri B; Brady RO; Zhuang Z
    Proc Natl Acad Sci U S A; 2015 Jan; 112(4):1137-42. PubMed ID: 25583479
    [TBL] [Abstract][Full Text] [Related]  

  • 20. High-throughput screening for small-molecule stabilizers of misfolded glucocerebrosidase in Gaucher disease and Parkinson's disease.
    Williams D; Glasstetter LM; Jong TT; Chen T; Kapoor A; Zhu S; Zhu Y; Calvo R; Gehrlein A; Wong K; Hogan AN; Vocadlo DJ; Jagasia R; Marugan JJ; Sidransky E; Henderson MJ; Chen Y
    Proc Natl Acad Sci U S A; 2024 Oct; 121(42):e2406009121. PubMed ID: 39388267
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 15.